Publicação
Investigating glioblastoma response to hypoxia
| datacite.subject.sdg | 03:Saúde de Qualidade | |
| datacite.subject.sdg | 09:Indústria, Inovação e Infraestruturas | |
| datacite.subject.sdg | 04:Educação de Qualidade | |
| dc.contributor.author | Chédeville, Agathe L. | |
| dc.contributor.author | Lourdusamy, Anbarasu | |
| dc.contributor.author | Monteiro, Ana Rita | |
| dc.contributor.author | Hill, Richard | |
| dc.contributor.author | Madureira, Patricia | |
| dc.date.accessioned | 2026-02-27T14:14:55Z | |
| dc.date.available | 2026-02-27T14:14:55Z | |
| dc.date.issued | 2020-08-27 | |
| dc.description.abstract | Glioblastoma (GB) is the most common and deadly type of primary malignant brain tumor with an average patient survival of only 15–17 months. GBs typically have hypoxic regions associated with aggressiveness and chemoresistance. Using patient derived GB cells, we characterized how GB responds to hypoxia. We noted a hypoxia-dependent glycolytic switch characterized by the up-regulation of HK2, PFKFB3, PFKFB4, LDHA, PDK1, SLC2A1/GLUT-1, CA9/CAIX, and SLC16A3/MCT-4. Moreover, many proangiogenic genes and proteins, including VEGFA, VEGFC, VEGFD, PGF/PlGF, ADM, ANGPTL4, and SERPINE1/PAI-1 were up-regulated during hypoxia. We detected the hypoxic induction of invasion proteins, including the plasminogen receptor, S100A10, and the urokinase plasminogen activator receptor, uPAR. Furthermore, we observed a hypoxia-dependent up-regulation of the autophagy genes, BNIP-3 and DDIT4 and of the multi-functional protein, NDRG1 associated with GB chemoresistance; and down-regulation of EGR1 and TFRC (Graphical abstract). Analysis of GB patient cohorts’ revealed differential expression of these genes in patient samples (except SLC16A3) compared to non-neoplastic brain tissue. High expression of SLC2A1, LDHA, PDK1, PFKFB4, HK2, VEGFA, SERPINE1, TFRC, and ADM was associated with significantly lower overall survival. Together these data provide important information regarding GB response to hypoxia which could support the development of more effective treatments for GB patients. | eng |
| dc.description.sponsorship | IF/00614/2014/CP12340006; UID/BIM/04773/2013CBMR1334 | |
| dc.identifier.doi | 10.3390/biomedicines8090310 | |
| dc.identifier.issn | 2227-9059 | |
| dc.identifier.uri | http://hdl.handle.net/10400.1/28288 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.publisher | MDPI | |
| dc.relation.ispartof | Biomedicines | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Glioblastoma | |
| dc.subject | Hypoxia | |
| dc.subject | Glycolysis | |
| dc.subject | Invasion | |
| dc.subject | Autophagy | |
| dc.subject | Tumor angiogenesis | |
| dc.title | Investigating glioblastoma response to hypoxia | eng |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 9 | |
| oaire.citation.startPage | 310 | |
| oaire.citation.title | Biomedicines | |
| oaire.citation.volume | 8 | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
| person.familyName | Monteiro | |
| person.familyName | Madureira | |
| person.givenName | Ana Rita | |
| person.givenName | Patricia | |
| person.identifier.ciencia-id | 7A19-1CD0-A439 | |
| person.identifier.ciencia-id | 6612-9A86-6929 | |
| person.identifier.orcid | 0000-0001-5694-5335 | |
| person.identifier.orcid | 0000-0002-4856-3908 | |
| person.identifier.scopus-author-id | 10340140500 | |
| relation.isAuthorOfPublication | bc9c943e-0aae-4685-b403-b12e560d68c3 | |
| relation.isAuthorOfPublication | a40de6a3-d52d-45dd-8620-cb94a22ebc8f | |
| relation.isAuthorOfPublication.latestForDiscovery | bc9c943e-0aae-4685-b403-b12e560d68c3 |